391
Pill imprint 391 has been identified as Oxaprozin 600 mg.
Oxaprozin is used in the treatment of rheumatoid arthritis; osteoarthritis; juvenile rheumatoid arthritis and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Oxaprozin 600 mg is not subject to the Controlled Substances Act.
See also related documents.
Oxaprozin Images
- Imprint:
-
391
- Strength:
- 600 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
methylcellulose
magnesium stearate
starch
sodium starch glycolate
polyethylene glycol
polysorbate 80
titanium dioxide
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 57664-0391
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5212 | A S Medication Solutions LLC (repackager) |
| 57866-2899 | Direct Dispensing Inc (repackager) |
| 18837-0118 | Innoviant Pharmacy Inc (repackager) |
| 21695-0100 | Rebel Distributors Corp (repackager) |
| 10544-0326 | Blenheim Pharmacal Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Oxaprozin resources
- Oxaprozin (Wolters Kluwer)
- oxaprozin (Cerner Multum)
- oxaprozin (Micromedex) - Includes Dosage Information
- Oxaprozin (AHFS DI)
- Oxaprozin Potassium (AHFS DI)
- Daypro Alta (FDA)
- Oxaprozin (FDA)
- Oxaprozin Tablets (FDA)
- Oxaprozin (Wolters Kluwer)
Search Again
